261 related articles for article (PubMed ID: 22936676)
21. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
[TBL] [Abstract][Full Text] [Related]
22. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y
J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
[TBL] [Abstract][Full Text] [Related]
23. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
24. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
Uhles S; Wang H; Bénardeau A; Prummer M; Brecheisen M; Sewing S; Tobalina L; Bosco D; Wollheim CB; Migliorini C; Sebokova E
Diabetes Obes Metab; 2011 Apr; 13(4):326-36. PubMed ID: 21205124
[TBL] [Abstract][Full Text] [Related]
25. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
26. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
[TBL] [Abstract][Full Text] [Related]
27. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice.
Okauchi S; Shimoda M; Obata A; Kimura T; Hirukawa H; Kohara K; Mune T; Kaku K; Kaneto H
Biochem Biophys Res Commun; 2016 Feb; 470(3):772-782. PubMed ID: 26505796
[TBL] [Abstract][Full Text] [Related]
29. Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase.
Huang Q; Bu S; Yu Y; Guo Z; Ghatnekar G; Bu M; Yang L; Lu B; Feng Z; Liu S; Wang F
Endocrinology; 2007 Jan; 148(1):81-91. PubMed ID: 17053028
[TBL] [Abstract][Full Text] [Related]
30. Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720.
Truong W; Emamaullee JA; Merani S; Anderson CC; James Shapiro AM
Am J Transplant; 2007 Aug; 7(8):2031-8. PubMed ID: 17617868
[TBL] [Abstract][Full Text] [Related]
31. Rare sugar D-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats.
Hossain A; Yamaguchi F; Matsunaga T; Hirata Y; Kamitori K; Dong Y; Sui L; Tsukamoto I; Ueno M; Tokuda M
Biochem Biophys Res Commun; 2012 Sep; 425(4):717-23. PubMed ID: 22877751
[TBL] [Abstract][Full Text] [Related]
32. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
[TBL] [Abstract][Full Text] [Related]
33. Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
Maiztegui B; Borelli MI; Madrid VG; Del Zotto H; Raschia MA; Francini F; Massa ML; Flores LE; Rebolledo OR; Gagliardino JJ
Clin Sci (Lond); 2011 Jan; 120(2):73-80. PubMed ID: 20795946
[TBL] [Abstract][Full Text] [Related]
34. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
35. [Study of the effects of immunosuppressive agents on human islet cells in vitro].
Cai JQ; Tan JM; Dong WP; Wang YF; Wang JB
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):654-6. PubMed ID: 15932724
[TBL] [Abstract][Full Text] [Related]
36. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
37. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
[TBL] [Abstract][Full Text] [Related]
38. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
39. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
40. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
